Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Dermatoendocrinol , 227-231
Pharmacokinetic studies in humans reveal: Peak plasma concentrations achieved within 5-20 minutes following subcutaneous injection Absolute bioavailability of approximately 6% with subcutaneous administration Volume of distribution ranging between 23.7-25.8 liters in adult subjects Rapid systemic distribution to target pituitary receptors The peptides small molecular size and water solubility facilitate efficient absorption from subcutaneous tissue, though first-pass degradation significantly limits bioavailability compared to intravenous administration
IL-11R-targeted nanostrategy empowers chemotherapy of relapsed and patient-derived osteosarcoma
TAp73 enhances the pentose phosphate pathway and supports cell proliferation
The FDA explicitly determined that Geref (sermorelin) was not withdrawn for reasons of safety or effectiveness
US$ 22.60
US$ 21.17
US$ 24.09
